United States health plan cancer concerns in 2019

Background: Cancer care is shifting from chemotherapy to more effective targeted immunotherapies. New therapies, some existing therapies with expanded indications (including maintenance) and many therapies with price increases require re-evaluation. Many agents are handled through specialty pharmaci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Drug Assess
Hauptverfasser: Brook, Richard A., Sax, Michael J., Carlisle, Jeffrey A., Smeeding, Jim E.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2019
Schlagworte:
Poster #7
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6764396/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1658330
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge